Cornerstone Investment Partners’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-34,070
Closed -$1.78M 203
2022
Q2
$1.78M Hold
34,070
0.12% 35
2022
Q1
$1.93M Hold
34,070
0.11% 35
2021
Q4
$1.75M Sell
34,070
-500
-1% -$24.5K 0.1% 39
2021
Q3
$1.71M Hold
34,570
0.1% 42
2021
Q2
$1.97M Hold
34,570
0.1% 43
2021
Q1
$2.1M Buy
34,570
+5,445
+19% +$301K 0.11% 41
2020
Q4
$1.56M Hold
29,125
0.09% 46
2020
Q3
$1.37M Buy
29,125
+5,545
+24% +$285K 0.1% 48
2020
Q2
$1.23M Hold
23,580
0.09% 47
2020
Q1
$1.13M Hold
23,580
0.07% 51
2019
Q4
$1.19M Hold
23,580
0.06% 56
2019
Q3
$1.11M Buy
23,580
+5,060
+27% +$231K 0.05% 57
2019
Q2
$872K Buy
18,520
+3,925
+27% +$181K 0.04% 61
2019
Q1
$703K Buy
+14,595
New +$731K 0.03% 63

Other funds holding CAH

Cornerstone Investment Partners's CAH Position: Q3 2022 in Review

Cornerstone Investment Partners sold out of Cardinal Health (CAH) in Q3 2022, closing a stake of 34,070 shares — an estimated $1.78M sold.

Cornerstone Investment Partners first reported a position in CAH in Q1 2019 and held it in 14 quarters. The position peaked at $2.1M in Q1 2021. 848 funds tracked by Wall St. Rank hold CAH as of Q3 2022.

  • Cornerstone Investment Partners reported no remaining Cardinal Health position as of Q3 2022 after selling out during the quarter.
  • Cornerstone Investment Partners sold 34,070 Cardinal Health shares in Q3 2022, an estimated $1.78M.
  • Cornerstone Investment Partners first reported a position in Cardinal Health in Q1 2019 and held it in 14 quarters.
  • Cornerstone Investment Partners's Cardinal Health position peaked at $2.1M in Q1 2021.
  • 848 funds tracked by Wall St. Rank held Cardinal Health as of Q3 2022.

Based on Cornerstone Investment Partners's 13F filing for Q3 2022, filed 4 Nov 2022.